Clinical trials: Abnormal Lip
Abnormal Lip
Study to Evaluate the Effectiveness, Safety and Long Term Safety of Saypha® FILLER Lidocaine for Lip Augmentation
This is a prospective, open-label, multicentre, randomized study conducted to evaluate the effectiveness, safety and long-term safety of Saypha® FILLER Lidocaine for lip augmentation.
- Trial name
- SayLip (NCT04917588)
- Testing
- Saypha® FILLER Lidocaine (HQ), Saypha® FILLER Lidocaine (C1)
- Where
- 3 sites in Austria
- Volunteers
- 114 people, healthy volunteers welcome
- Sponsor
- Croma-Pharma GmbH